Vitrocap Capsules Pack of 90 Capsules

Product Information

During a roundtable hosted in partnership with VivaQuity, OT speaks to two UK optometrists about their current management of floaters in practice, discusses experiences of the VitroCap N with a German ophthalmologist, and hears from a vision scientist from the Republic of Irelandabout the years of research that have gone into confirming the supplement’s viability. Making healthy lifestyle changes can sometimes help reduce your chances of getting high blood pressure and help lower your blood pressure if it's already high.

The question offered a three-response choice, which were rated as follows: My condition has become stable and I have not been bothered by my floaters = 0; My floaters have been intermittently and moderately bothersome = 1; or My floaters have been persistently bothersome = 2. Patient responses were reported as simple frequency distributions. In general terms, I would really stress the importance of the eye care community to be alerted to peer reviewed science and to trust that type of science.” Experiences of VitroCap N Over 20: how many years Professor John M Nolan and colleagues at the Nutrition Research Centre Ireland have been working on how targeted nutrition can be beneficial to the eye, particularly with regards to macular degeneration Six: the number of months taken to see a benefit to those taking VitroCap N in terms of how they felt in their daily life, their contrast sensitivity, and the size of their floaters Ingredients: L-lysine hydrochloride, citrus fruit extract (Citrus aurantium L.), capsule shell (coating agent: Hydroxypropyl methyl cellulose, colouring food: spirulina and apple concentrate, invert sugar), filler: microcrystalline cellulose, L-ascorbic acid (vitamin C); grape seed extract (Vitis vinifera L.), Zinc oxide, anti-caking agents: magnesium salts of fatty acids, silicon dioxideSebag J, Yee KMP, Wa CA, et al. Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile. Retina. 2014;34:1062–1068 He added: “You have to discuss that. You have to say to people, ‘if you do get any side effects, if you get a headache, if you get diarrhoea, then you stop, like [you would with] anything else.’”

The eye is perfectly shaped for its function: the trapping and transmission of undisturbed and unaltered light signals to the recipient cells (receptors) of the retina. Essential to this process is transparent media, namely that of the cornea, the lens and the vitreous. Certain changes in these structures e.g. clouding or clumping, affect the transmission of the light and thereby the quality of vision. There are a couple of points that you have to discuss with people,” he said. “One thing we should let people know is the daily recommended limit. If you look at the daily recommended limit for zinc, or for vitamin C, the tablets are well within that, for men and women.” C. 19–23. [Ageenkova EK. Psikhologicheskie faktory v razvitii serdechno-sosudistykh zabolevaniy. Psikhiatriya, psikhoterapiya i klinicheskaya psikhologiya. 2002;(3):19-23. (In Russ.)] Nolan wants to stress that the micronutrient is “not a silver bullet at this point in time,” but rather something that patients need to understand the value of complying with. After analysing the existing literature on the metabolism and micronutrient supply of the vitreous body, the FLIES researchers at the Nutrition Research Centre Ireland (NRCI), which is renowned for its research on the correlation between nutrition and eye diseases, came to the conclusion that oxidative stress is associated with an undersupply of antioxidants from food (similar to other chronic eye diseases such as AMD and cataracts) and subsequent glycation of collagen fibres (crosslinking via sugar molecules). These two processes may be key mechanisms of vitreous degeneration. Conversely, if the supply of micronutrients found in the vitreous body is optimised, an improvement should potentially be detectable.VitroCap®N also contains precious phytochemicals obtained from grape seed extracts (polyphenols known as proanthocyanidins) and from citrus fruit (citrus flavonoids) and L-lysine, an essential amino acid, which the human body cannot produce by itself. Six: years since optometrist Emmanuel Ankamah joined the Nutrition Research Centre Ireland research team to start his PhD investigating the nutrition of the vitreous

The FLIES study shows a significant decrease after six months of dietary supplementation with a formulation consisting of 125 mg L-lysine, 40 mg vitamin C, 26.3 mg grape seed extract, 5 mg zinc and 60 mg citrus flavonoids (available as VitroCap®N) in subjective visual symptoms (67%), a significant decrease in vitreous opacity (success rate 76.9%) and a significant improvement in contrast sensitivity compared to placebo. He added: “Optometrists sometimes say, ‘I’m not a salesperson, I’m not selling tablets, I’m not selling glasses. I’m a clinician.’ But we need to try and get beyond that and focus on the quality of life. That’s a big message: that they will be doing the right thing for a large proportion of their patients who are struggling with floaters.” It’s incumbent on the optometrist to further pursue and ask questions of the patient who says they have floaters Optometrist and EyeTools co-founder, Dr Frank Eperjesi This study is the first to assess the impact of targeted nutritional supplementation on patient suffering associated with vitreous floaters, in the context of a randomized, double-blind, placebo-controlled clinical trial. Here, we report a significant decrease in subjective visual discomfort from floaters, a significant decrease in vitreous opacity area, and a significant improvement in contrast sensitivity after 6 months of supplementation with the active formulation. The observed benefit in the active group confirms our initial hypothesis that dietary intake of a formulation of antioxidative and antiglycation micronutrients could avail relevant micronutrients capable of mitigating the mechanisms underlying vitreous degeneration, thereby decreasing the visual discomfort associated with vitreous floaters.

Upozornenie: Nie je určené pre deti. Tehotné a dojčiace ženy by samali pred začatím užívania poradiť so svoojím lekárom. Uchovávať mimo dosahu detí. Ustanovená odporúčaná denná dávka sa nesmie presiahnuť. Výživový doplnok sa nesmie používať ako náhrada rozmanitej stravy. Informácia od dodávateľa *